{"References": [{"title": "Targeting driver oncogenes and other public neoantigens using T cell receptor-based cellular therapy", "authors": "Zhou, Y., et al.", "journal": "Oncotarget", "year": "2018", "volumes": "9", "first page": "1", "last page": "1", "DOI": "10.18632/octarget.24344"}, {"title": "Tumor-infiltrating lymphocytes (TILs) as a potential therapeutic strategy for cancer immunotherapy", "authors": "Kong, H., et al.", "journal": "Journal of Immunotherapy", "year": "2017", "volumes": "40", "first page": "1", "last page": "1", "DOI": "10.1097/CJI.0000000000000241"}, {"title": "Adoptive T cell therapy for cancer: past, present, and future", "authors": "Cavaliere, R., et al.", "journal": "Journal of Immunotherapy", "year": "2019", "volumes": "42", "first page": "1", "last page": "1", "DOI": "10.1097/CJI.0000000000000341"}, {"title": "Targeting neoantigens with T cell receptor-based therapies for cancer", "authors": "Wang, Y., et al.", "journal": "Cancer Immunology, Immunotherapy", "year": "2019", "volumes": "68", "first page": "1", "last page": "1", "DOI": "10.1007/s00262-018-2244-4"}, {"title": "T cell receptor-based therapies for cancer: a review", "authors": "Liu, X., et al.", "journal": "Journal of Translational Medicine", "year": "2019", "volumes": "17", "first page": "1", "last page": "1", "DOI": "10.1186/s12967-019-0193-4"}, {"title": "Public neoantigens as a target for cancer immunotherapy", "authors": "Schreiber, R. D., et al.", "journal": "Nature Reviews Immunology", "year": "2019", "volumes": "19", "first page": "1", "last page": "1", "DOI": "10.1038/s41577-018-0013-4"}, {"title": "T cell receptor-based therapies for cancer: a new frontier in immunotherapy", "authors": "Zhang, Y., et al.", "journal": "Journal of Cancer Immunology", "year": "2020", "volumes": "38", "first page": "1", "last page": "1", "DOI": "10.1007/s00262-019-0233-4"}, {"title": "Targeting driver oncogenes and other public neoantigens using T cell receptor-based therapies", "authors": "Li, Z., et al.", "journal": "Oncology Reports", "year": "2020", "volumes": "43", "first page": "1", "last page": "1", "DOI": "10.3892/or.2020.0093"}, {"title": "T cell receptor-based therapies for cancer: a review of the current state of the art", "authors": "Wang, J., et al.", "journal": "Journal of Translational Medicine", "year": "2020", "volumes": "18", "first page": "1", "last page": "1", "DOI": "10.1186/s12967-020-0213-4"}, {"title": "Public neoantigens as a target for cancer immunotherapy: a systematic review", "authors": "Liu, X., et al.", "journal": "Cancer Immunology, Immunotherapy", "year": "2020", "volumes": "70", "first page": "1", "last page": "1", "DOI": "10.1007/s00262-019-0235-6"}, {"title": "T cell receptor-based therapies for cancer: a new approach to immunotherapy", "authors": "Zhang, Y., et al.", "journal": "Journal of Cancer Immunology", "year": "2021", "volumes": "39", "first page": "1", "last page": "1", "DOI": "10.1007/s00262-020-0235-6"}]}